trending Market Intelligence /marketintelligence/en/news-insights/trending/kjcs-7k6skbsrcfsm5fytw2 content esgSubNav
In This List

Miragen Therapeutics looking to raise funds

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Miragen Therapeutics looking to raise funds

Miragen Therapeutics is looking to sell 7 million shares of the company to raise funds for working capital and general corporate purposes.

The Boulder, Colo.-based biopharmaceutical company will price the underwritten public offering at a later date.

Jefferies LLC, Evercore Group LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers of the offering, with Wedbush Securities Inc. and Oppenheimer & Co. Inc. acting as co-lead managers.

The underwriters can buy up to an additional 1,050,000 shares of the company, which is developing treatments for cancer and heart disease.